Previous close | 1.9500 |
Open | 1.8900 |
Bid | 1.8800 x 545600 |
Ask | 1.9700 x 532400 |
Day's range | 1.8900 - 1.8900 |
52-week range | 1.8000 - 2.8800 |
Volume | |
Avg. volume | 89 |
Market cap | 3.141B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.1300 |
Earnings date | 31 July 2024 - 05 Aug 2024 |
Forward dividend & yield | 0.07 (3.65%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | N/A |
Sumitomo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new program to develop functional chemicals with synthetic biology and expand upon the companies' existing biomanufacturing partnership.